News Image

NASDAQ:LNTH is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.

By Mill Chart

Last update: Feb 28, 2024

Take a closer look at LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a remarkable value stock uncovered by our stock screener. NASDAQ:LNTH excels in fundamentals and maintains a very reasonable valuation. Let's break it down further.

Valuation Insights: NASDAQ:LNTH

ChartMill assigns a proprietary Valuation Rating to each stock. The score is computed by evaluating various valuation aspects, like price to earnings and free cash flow, both absolutely as relative to the market and industry. NASDAQ:LNTH was assigned a score of 7 for valuation:

  • A Price/Earnings ratio of 10.96 indicates a reasonable valuation of LNTH.
  • Based on the Price/Earnings ratio, LNTH is valued cheaply inside the industry as 96.43% of the companies are valued more expensively.
  • LNTH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.89.
  • The Price/Forward Earnings ratio is 10.73, which indicates a very decent valuation of LNTH.
  • 96.94% of the companies in the same industry are more expensive than LNTH, based on the Price/Forward Earnings ratio.
  • LNTH is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.57, which is the current average of the S&P500 Index.
  • LNTH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LNTH is cheaper than 95.41% of the companies in the same industry.
  • 91.84% of the companies in the same industry are more expensive than LNTH, based on the Price/Free Cash Flow ratio.
  • The decent profitability rating of LNTH may justify a higher PE ratio.

How do we evaluate the Profitability for NASDAQ:LNTH?

Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:LNTH has achieved a 7:

  • LNTH has a Return On Assets of 19.79%. This is amongst the best in the industry. LNTH outperforms 98.47% of its industry peers.
  • LNTH has a Return On Equity of 40.04%. This is amongst the best in the industry. LNTH outperforms 98.98% of its industry peers.
  • The Return On Invested Capital of LNTH (26.97%) is better than 98.98% of its industry peers.
  • LNTH has a better Profit Margin (25.20%) than 96.43% of its industry peers.
  • LNTH's Profit Margin has improved in the last couple of years.
  • LNTH has a Operating Margin of 38.31%. This is amongst the best in the industry. LNTH outperforms 99.49% of its industry peers.
  • LNTH's Operating Margin has improved in the last couple of years.
  • The Gross Margin of LNTH (63.71%) is better than 66.33% of its industry peers.

How do we evaluate the Health for NASDAQ:LNTH?

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:LNTH scores a 8 out of 10:

  • LNTH has an Altman-Z score of 5.90. This indicates that LNTH is financially healthy and has little risk of bankruptcy at the moment.
  • LNTH's Altman-Z score of 5.90 is amongst the best of the industry. LNTH outperforms 80.10% of its industry peers.
  • The Debt to FCF ratio of LNTH is 2.64, which is a good value as it means it would take LNTH, 2.64 years of fcf income to pay off all of its debts.
  • LNTH's Debt to FCF ratio of 2.64 is amongst the best of the industry. LNTH outperforms 89.29% of its industry peers.
  • LNTH has a Current Ratio of 5.80. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.80, LNTH is in the better half of the industry, outperforming 74.49% of the companies in the same industry.
  • A Quick Ratio of 5.45 indicates that LNTH has no problem at all paying its short term obligations.
  • LNTH has a Quick ratio of 5.45. This is in the better half of the industry: LNTH outperforms 77.04% of its industry peers.

Growth Assessment of NASDAQ:LNTH

ChartMill assigns a Growth Rating to each stock, ranging from 0 to 10. This rating is determined by analyzing different growth elements, including EPS and revenue growth, spanning both historical and future figures. In the case of NASDAQ:LNTH, the assigned 8 reflects its growth potential:

  • LNTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.63%, which is quite impressive.
  • LNTH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 45.36% yearly.
  • Looking at the last year, LNTH shows a very strong growth in Revenue. The Revenue has grown by 38.64%.
  • LNTH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.43% yearly.
  • LNTH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.43% yearly.
  • The Revenue is expected to grow by 10.13% on average over the next years. This is quite good.

More Decent Value stocks can be found in our Decent Value screener.

Our latest full fundamental report of LNTH contains the most current fundamental analsysis.

Disclaimer

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (4/25/2024, 3:20:01 PM)

After market: 65.2 0 (0%)

65.2

-0.01 (-0.02%)

LNTH News

News Image2 days ago - ChartmillNASDAQ:LNTH is not too expensive for the growth it is showing.

In the world of growth stocks, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) shines as a value proposition.

News Image7 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
News Image7 days ago - Lantheus Holdings, Inc.Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference...

News Image8 days ago - ChartmillNASDAQ:LNTH: a strong growth stock preparing for the next leg up?.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH) qualifies as a high growth stock and is consolidating.

News Image13 days ago - The Motley Fool2 Magnificent Stocks You Probably Never Heard Of

You might not have heard of these stocks, but they're worth putting on your radar.

News Image14 days ago - ChartmillInvestors should take notice of NASDAQ:LNTH—it offers a great deal for the fundamentals it presents.

LANTHEUS HOLDINGS INC (NASDAQ:LNTH), an undervalued stock with good fundamentals.

News Image15 days ago - InvestorPlaceWall Street Favorites: 3 Russell 2000 Stocks With Strong Buy Ratings for April 2024

Explore three Russell 2000 stocks with strong buy ratings for April 2024, offering high growth potential and lower valuations.

News Image23 days ago - Market News VideoInteresting LNTH Put And Call Options For May 17th
News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024
News Image2 months ago - Lantheus Holdings, Inc.Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024

BEDFORD, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...

News Image2 months ago - Lantheus Holdings, Inc.Lantheus Announces the FDA Approval of DEFINITY® (Perflutren Lipid Microsphere) for Pediatric Patients

DEFINITY is the #1 utilized ultrasound enhancing agent in the U.S. for patients with suboptimal echocardiograms

LNTH Links
Follow us for more